UK-based researchers believe personalised treatment for breast cancer is within sight after uncovering what they say is the most detailed picture to date of which genetic variations contribute to development of the disease.
The Society for Virology (GfV) which promotes virology through the increase and exchange of research within German speaking countries, as well as via cooperation with other scientific societies, announced this year that a new test can unambiguously confirm the diagnosis of a Zika virus infection – leading to fast diagnosis and identification of an infection.
Thermo Scientific presents its TSX505 Series - undercounter refrigerators designed to provide sustainable cold storage for demanding applications.
The association of biofilms with multi-drug resistance has highlighted the need for further understanding of biofilms and for anti-biofilm strategies.
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution.
Many women are turning to egg freezing to promote fertility, but what happens when it isn't an option because of special medical or other conditions? And, what option is there for women who want to preserve hormonal function, not just fertility?
Summer colds might seem rare, but people are actually just as likely to catch one in the summer as in the winter.
A new test may help to identify breast cancer patients with the lowest risk of death, therefore helping them to avoid unnecessarily aggressive treatment.
A certain immune reaction is the key, not to slowing atherosclerosis like cholesterol-lowering drugs do, but instead to reversing a disease that gradually blocks arteries to cause heart attacks and strokes. This is the finding of a study in mice led by researchers at NYU Langone Medical Center.
Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.
Ares Genetics GmbH, a wholly-owned subsidiary of Curetis GmbH and a developer of pioneering solutions for the detection of genetic resistances in pathogens, announced that the project "GEAR - Predicting Antibiotic Resistances with Genetic Data" has been awarded in the competition "Landmarks in the Land of Ideas".
The University of Southern California (USC) Norris Comprehensive Cancer Center is actively recruiting for a clinical trial that is researching the effectiveness of a breath test for breast cancer diagnostics. The BreathLink device, manufactured by Menssana Research, Inc., captures a two-minute sample of a patient’s breath and provides immediate results on whether there are indications of breast…
There hasn't been a gold standard for how orthopedic spine surgeons promote new bone growth in patients, but now Northwestern University scientists have designed a bioactive nanomaterial that is so good at stimulating bone regeneration it could become the method surgeons prefer.
A vaccine to immunise people against high levels of cholesterol and the narrowing of the arteries caused by build-up of fatty material (atherosclerosis) may be possible following successful results in mice. Now, a phase I trial in patients has started to see if the findings translate to humans.
The population in Germany is more physically active than the European average. Regarding smoking, the data for Germany are quite close to the European average. However, the country does not do so well in other areas of health-related behaviour: Germany has the third lowest level of fruit consumption and the proportion of heavy episodic drinkers is above average.
Comprehensive examinations of 143 refugee patients hailing mostly from Afghanistan and Syria, which were conducted between June and December 2015, showed a high prevalence of MRSA, ESBL and MDRGN upon hospital admission. The figures exceed not only those of the general population but, alarmingly, also those found in high-risk groups, such as residents of nursing homes or home care service…
Laboratories are an essential part of effective modern healthcare. They provide clinicians with vital information that helps them make life-saving decisions, diagnose conditions and monitor patient treatment.
Scientists have discovered that dying tumor cells release small pieces of their DNA into the bloodstream. These pieces are called circulating tumor DNA (ctDNA) or circulating cell-free DNA (ccfDNA).
'Blood is a very special juice’ – something even Goethe’s Mephistopheles knew. Medics have also known this for centuries, so it’s nothing new that the ‘juice’ and its properties receive a lot of attention in medicine. However, what is new is that dealing with the use of blood through patient blood management (PBM) is coming to the fore.
Since autumn 2016 a small tube has been making daily life easier for users and patients. A simple but effective addition now offers many new advantages in analysis, the manufacturer reports.
The Company TECO Medical Instruments + Trading GmbH, Germany is working since 25 years intensive in development, production and sales of coagulation analysers, which are distributed and supported through the worldwide distributors into hospitals and Coagulation laboratories.
While IA’s (Immunoassay) has been the most used technic for clinical analysis, the shift to LC-MS / MS is constantly increasing for several type of analysis like immunosuppressant, vitamin D or steroids panel, but also for several new assays including anti-coagulants, antibiotics, plasma renin activity, etc. The change from Immunoassay to LC-MS / MS could have been faster if sample…
A new drive to increase the clinical effectiveness of laboratory medicine and take the discipline into a new era is being launched.
Following its success in establishing reference methods and values for a range of simple molecules, International Federation of Clinical Chemistry and Laboratory Medicine’s Scientific Division takes on the challenge of harmonization for hormones and endocrine tests.
In our interview with the physician Dr. Fabian Berger, we want to know about the advantages of molecular biological procedures compared to conventional C. difficile diagnostics.
